▶ 調査レポート

世界のコロナウイルス用ワクチン市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Coronavirus Vaccine Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のコロナウイルス用ワクチン市場規模・現状・予測(2021年-2027年) / Global Coronavirus Vaccine Market Size, Status and Forecast 2021-2027 / QFJ1-5437資料のイメージです。• レポートコード:QFJ1-5437
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:新技術
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、コロナウイルス用ワクチンの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(コロナウイルス不活化ワクチン、弱毒生コロナウイルスワクチン、Sタンパク質系コロナウイルスワクチン)、用途別市場規模(病院、診療所、研究所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・コロナウイルス用ワクチンの市場動向
・企業の競争状況、市場シェア
・コロナウイルス用ワクチンの種類別市場規模と予測2016-2027(コロナウイルス不活化ワクチン、弱毒生コロナウイルスワクチン、Sタンパク質系コロナウイルスワクチン)
・コロナウイルス用ワクチンの用途別市場規模と予測2016-2027(病院、診療所、研究所、その他)
・コロナウイルス用ワクチンの北米市場規模2016-2027(アメリカ、カナダ)
・コロナウイルス用ワクチンの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・コロナウイルス用ワクチンのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・コロナウイルス用ワクチンの中南米市場規模2016-2027(メキシコ、ブラジル)
・コロナウイルス用ワクチンの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Іnоvіо Рhаrmасеutісаlѕ、Моdеrnа、Nоvаvах、Рrоtеіn Роtеntіаl、АlрhаVах、Ѕуnаіrgеn РLС、NаnоVіrісіdеѕ、GGеnеСurе)
・結論

Coronavirus vaccines refer to biological products made from coronaviruses for vaccination. It mainly includes inactivated coronavirus vaccine, live attenuated coronavirus vaccine, coronavirus vaccine based on S protein and so on.

In 2021, the global Coronavirus Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Coronavirus Vaccine status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Coronavirus Vaccine development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Coronavirus Vaccine Scope and Market Size
Coronavirus Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Coronavirus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Coronavirus Inactivated Vaccine
Live Attenuated Coronavirus Vaccine
Coronavirus Vaccine Based On S Protein

Segment by Application
Hospital
Clinic
Research Institute
Other

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Іnоvіо Рhаrmасеutісаlѕ
Моdеrnа
Nоvаvах
Рrоtеіn Роtеntіаl
АlрhаVах
Ѕуnаіrgеn РLС
NаnоVіrісіdеѕ
GGеnеСurе

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Coronavirus Vaccine Market Size Growth Rate by Type (2021-2027)
1.2.2 Coronavirus Inactivated Vaccine
1.2.3 Live Attenuated Coronavirus Vaccine
1.2.4 Coronavirus Vaccine Based On S Protein
1.3 Market by Application
1.3.1 Global Coronavirus Vaccine Market Share by Application (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Coronavirus Vaccine Market Size
2.2 Coronavirus Vaccine Market Size by Regions
2.2.1 Coronavirus Vaccine Growth Rate by Regions (2021-2027)
2.2.2 Coronavirus Vaccine Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Coronavirus Vaccine Revenue by Players (2020-2021)
3.2 Coronavirus Vaccine Key Players Headquaters and Area Served
3.3 Key Players Coronavirus Vaccine Product/Solution/Service
3.4 Date of Enter into Coronavirus Vaccine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global Coronavirus Vaccine Market Size by Type (2021-2027)
4.2 Global Coronavirus Vaccine Market Size by Application (2021-2027)

5 North America
5.1 North America Coronavirus Vaccine Market Forecast (2021-2027)
5.2 Coronavirus Vaccine Key Players in North America
5.3 North America Coronavirus Vaccine Market Size by Type
5.4 North America Coronavirus Vaccine Market Size by Application
6.4.4 Canada

6 Europe
6.1 Europe Coronavirus Vaccine Market Forecast (2021-2027)
6.2 Coronavirus Vaccine Key Players in Europe
6.3 Europe Coronavirus Vaccine Market Size by Type
6.4 Europe Coronavirus Vaccine Market Size by Application

7 Japan
7.1 Japan Coronavirus Vaccine Market Forecast (2021-2027)
7.2 Coronavirus Vaccine Key Players in Europe
7.3 Japan Coronavirus Vaccine Market Size by Type
7.4 Japan Coronavirus Vaccine Market Size by Application

8 Rest of World
8.1 China
8.1.1 China Coronavirus Vaccine Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Coronavirus Vaccine Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Coronavirus Vaccine Market Analysis
8.3.2 Key Players in India

9 International Player Profiles
9.1 Іnоvіо Рhаrmасеutісаlѕ
9.1.1 Іnоvіо Рhаrmасеutісаlѕ Company Details
9.1.2 Іnоvіо Рhаrmасеutісаlѕ Description and Business Overview
9.1.3 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Introduction
9.1.4 Іnоvіо Рhаrmасеutісаlѕ Revenue in Coronavirus Vaccine Business (2020-2021)
9.1.5 Іnоvіо Рhаrmасеutісаlѕ Recent Development
9.2 Моdеrnа
9.2.1 Моdеrnа Company Details
9.2.2 Моdеrnа Description and Business Overview
9.2.3 Моdеrnа Coronavirus Vaccine Introduction
9.2.4 Моdеrnа Revenue in Coronavirus Vaccine Business (2020-2021)
9.2.5 Моdеrnа Recent Development
9.3 Nоvаvах
9.3.1 Nоvаvах Company Details
9.3.2 Nоvаvах Description and Business Overview
9.3.3 Nоvаvах Coronavirus Vaccine Introduction
9.3.4 Nоvаvах Revenue in Coronavirus Vaccine Business (2020-2021)
9.3.5 Nоvаvах Recent Development
9.4 Рrоtеіn Роtеntіаl
9.4.1 Рrоtеіn Роtеntіаl Company Details
9.4.2 Рrоtеіn Роtеntіаl Description and Business Overview
9.4.3 Рrоtеіn Роtеntіаl Coronavirus Vaccine Introduction
9.4.4 Рrоtеіn Роtеntіаl Revenue in Coronavirus Vaccine Business (2020-2021)
9.4.5 Рrоtеіn Роtеntіаl Recent Development
9.5 АlрhаVах
9.5.1 АlрhаVах Company Details
9.5.2 АlрhаVах Description and Business Overview
9.5.3 АlрhаVах Coronavirus Vaccine Introduction
9.5.4 АlрhаVах Revenue in Coronavirus Vaccine Business (2020-2021)
9.5.5 АlрhаVах Recent Development
9.6 Ѕуnаіrgеn РLС
9.6.1 Ѕуnаіrgеn РLС Company Details
9.6.2 Ѕуnаіrgеn РLС Description and Business Overview
9.6.3 Ѕуnаіrgеn РLС Coronavirus Vaccine Introduction
9.6.4 Ѕуnаіrgеn РLС Revenue in Coronavirus Vaccine Business (2020-2021)
9.6.5 Ѕуnаіrgеn РLС Recent Development
9.7 NаnоVіrісіdеѕ
9.7.1 NаnоVіrісіdеѕ Company Details
9.7.2 NаnоVіrісіdеѕ Description and Business Overview
9.7.3 NаnоVіrісіdеѕ Coronavirus Vaccine Introduction
9.7.4 NаnоVіrісіdеѕ Revenue in Coronavirus Vaccine Business (2020-2021)
9.7.5 NаnоVіrісіdеѕ Recent Development
9.8 GGеnеСurе
9.8.1 GGеnеСurе Company Details
9.8.2 GGеnеСurе Description and Business Overview
9.8.3 GGеnеСurе Coronavirus Vaccine Introduction
9.8.4 GGеnеСurе Revenue in Coronavirus Vaccine Business (2020-2021)
9.8.5 GGеnеСurе Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global Coronavirus Vaccine Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Coronavirus Inactivated Vaccine
Table 3. Key Players of Live Attenuated Coronavirus Vaccine
Table 4. Key Players of Coronavirus Vaccine Based On S Protein
Table 5. Global Coronavirus Vaccine Market Size Growth by Application (2021-2027) (US$ Million)
Table 6. Global Coronavirus Vaccine Market Size by Regions (2021-2027) (US$ Million)
Table 7. Global Coronavirus Vaccine Market Share by Regions (2021-2027)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global Coronavirus Vaccine Revenue by Players (2020-2021) (US$ Million)
Table 11. Global Coronavirus Vaccine Market Share by Players (2020-2021)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players Coronavirus Vaccine Product Solution and Service
Table 14. Date of Enter into Coronavirus Vaccine Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Coronavirus Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 17. Global Coronavirus Vaccine Market Size Share by Type (2021-2027)
Table 18. Global Coronavirus Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 19. Global Coronavirus Vaccine Market Size Share by Application (2021-2027)
Table 20. North America Key Players Coronavirus Vaccine Revenue (2020-2021) (US$ Million)
Table 21. North America Key Players Coronavirus Vaccine Market Share (2020-2021)
Table 22. North America Coronavirus Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 23. North America Coronavirus Vaccine Market Share by Type (2021-2027)
Table 24. North America Coronavirus Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 25. North America Coronavirus Vaccine Market Share by Application (2021-2027)
Table 26. Europe Key Players Coronavirus Vaccine Revenue (2020-2021) (US$ Million)
Table 27. Europe Key Players Coronavirus Vaccine Market Share (2020-2021)
Table 28. Europe Coronavirus Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 29. Europe Coronavirus Vaccine Market Share by Type (2021-2027)
Table 30. Europe Coronavirus Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 31. Europe Coronavirus Vaccine Market Share by Application (2021-2027)
Table 32. Japan Key Players Coronavirus Vaccine Revenue (2020-2021) (US$ Million)
Table 33. Japan Key Players Coronavirus Vaccine Market Share (2020-2021)
Table 34. Japan Coronavirus Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 35. Japan Coronavirus Vaccine Market Share by Type (2021-2027)
Table 36. Japan Coronavirus Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 37. Japan Coronavirus Vaccine Market Share by Application (2021-2027)
Table 38. Key Players in China
Table 39. Key Players in Southeast Asia
Table 40. Key Players in India
Table 41. Іnоvіо Рhаrmасеutісаlѕ Company Details
Table 42. Іnоvіо Рhаrmасеutісаlѕ Description and Business Overview
Table 43. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Product
Table 44. Іnоvіо Рhаrmасеutісаlѕ Revenue in Coronavirus Vaccine Business 2020 and 2021
Table 45. Іnоvіо Рhаrmасеutісаlѕ Recent Development
Table 46. Моdеrnа Company Details
Table 47. Моdеrnа Description and Business Overview
Table 48. Моdеrnа Coronavirus Vaccine Product
Table 49. Моdеrnа Revenue in Coronavirus Vaccine Business 2020 and 2021
Table 50. Моdеrnа Recent Development
Table 51. Nоvаvах Company Details
Table 52. Nоvаvах Description and Business Overview
Table 53. Nоvаvах Coronavirus Vaccine Product
Table 54. Nоvаvах Revenue in Coronavirus Vaccine Business 2020 and 2021
Table 55. Nоvаvах Recent Development
Table 56. Рrоtеіn Роtеntіаl Company Details
Table 57. Рrоtеіn Роtеntіаl Description and Business Overview
Table 58. Рrоtеіn Роtеntіаl Coronavirus Vaccine Product
Table 59. Рrоtеіn Роtеntіаl Revenue in Coronavirus Vaccine Business 2020 and 2021
Table 60. Рrоtеіn Роtеntіаl Recent Development
Table 61. АlрhаVах Company Details
Table 62. АlрhаVах Description and Business Overview
Table 63. АlрhаVах Coronavirus Vaccine Product
Table 64. АlрhаVах Revenue in Coronavirus Vaccine Business 2020 and 2021
Table 65. АlрhаVах Recent Development
Table 66. Ѕуnаіrgеn РLС Company Details
Table 67. Ѕуnаіrgеn РLС Description and Business Overview
Table 68. Ѕуnаіrgеn РLС Coronavirus Vaccine Product
Table 69. Ѕуnаіrgеn РLС Revenue in Coronavirus Vaccine Business 2020 and 2021
Table 70. Ѕуnаіrgеn РLС Recent Development
Table 71. NаnоVіrісіdеѕ Company Details
Table 72. NаnоVіrісіdеѕ Description and Business Overview
Table 73. NаnоVіrісіdеѕ Coronavirus Vaccine Product
Table 74. NаnоVіrісіdеѕ Revenue in Coronavirus Vaccine Business 2020 and 2021
Table 75. NаnоVіrісіdеѕ Recent Development
Table 76. GGеnеСurе Company Details
Table 77. GGеnеСurе Description and Business Overview
Table 78. GGеnеСurе Coronavirus Vaccine Product
Table 79. GGеnеСurе Revenue in Coronavirus Vaccine Business 2020 and 2021
Table 80. GGеnеСurе Recent Development
Table 81. Coronavirus Vaccine Market Trends
Table 82. Coronavirus Vaccine Market Drivers
Table 83. Coronavirus Vaccine Market Challenges
Table 84. Coronavirus Vaccine Market Restraints
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Coronavirus Vaccine Market Share by Type in 2021 & 2027
Figure 2. Coronavirus Inactivated Vaccine Features
Figure 3. Live Attenuated Coronavirus Vaccine Features
Figure 4. Coronavirus Vaccine Based On S Protein Features
Figure 5. Global Coronavirus Vaccine Market Share by Application in 2021 & 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Coronavirus Vaccine Report Years Considered
Figure 11. Global Coronavirus Vaccine Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 12. Global Coronavirus Vaccine Market Share by Regions (2020-2027)
Figure 13. Global Coronavirus Vaccine Market Share by Players in 2021
Figure 14. Global Coronavirus Vaccine Market Size Market Share by Type (2021-2027)
Figure 15. Global Coronavirus Vaccine Market Size Market Share by Application (2021-2027)
Figure 16. Global Coronavirus Vaccine Revenue Market Share by Application in 2021
Figure 17. North America Coronavirus Vaccine Market Size 2021-2027 (US$ Million)
Figure 18. Europe Coronavirus Vaccine Market Size 2021-2027 (US$ Million)
Figure 19. Japan Coronavirus Vaccine Market Size 2021-2027 (US$ Million)
Figure 20. Coronavirus Vaccine Market Size in China (2021-2027) (US$ Million)
Figure 21. Coronavirus Vaccine Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 22. Coronavirus Vaccine Market Size in India (2021-2027) (US$ Million)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed